Vibramycin IV
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Vibramycin Intravenous
VIBRAMYCIN®
(doxycycline hyclate) for Injection
FOR INTRAVENOUS USE ONLY
DRUG DESCRIPTION
Vibramycin (doxycycline hyclate for injection) Intravenous is a broad-spectrum antibiotic synthetically derived from oxytetracycline, and is available as Vibramycin Hyclate (doxycycline hydrochloride hemiethanolate hemihydrate). The chemical designation of this light-yellow crystalline powder is alpha-6-deoxy-5-oxytetracycline. Doxycycline has a high degree of lipoid solubility and a low affinity for calcium binding. It is highly stable in normal human serum.
Vibramycin has the following structural formula:
Last reviewed on RxList: 3/4/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Vibramycin Intravenous Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
